APO Research

APO RESEARCH · REPORT

Opioid Pain Patche

Selected research

Market Outlook & Growth Opportunities

Global Opioid Pain Patche Market Outlook and Growth Opportunities 2026

Market perspective

The global Opioid Pain Patche market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Opioid Pain Patche is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Pain Patche is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Pain Patche is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Opioid Pain Patche market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Opioid Pain Patche market include Teva Pharmaceutical Industries, Sanofi, Novartis, GlaxoSmithKline, Viatris, Teikoku Seiyaku, Nichiban, Mentholatum and Johnson & Johnson Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Opioid Pain Patche market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Pain Patche and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Pain Patche sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Pain Patche market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Pain Patche Segment by Company

Teva Pharmaceutical Industries

Sanofi

Novartis

GlaxoSmithKline

Viatris

Teikoku Seiyaku

Nichiban

Mentholatum

Johnson & Johnson Services

Hisamitsu Pharmaceutical

Opioid Pain Patche Segment by Type

Opioid Patches

Non-opioid Patches

Opioid Pain Patche Segment by Application

Retail Pharmacies

Online pharmacies

Hospital Pharmacies

Opioid Pain Patche Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Opioid Pain Patche status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Opioid Pain Patche market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Opioid Pain Patche significant trends, drivers, influence factors in global and regions.

6. To analyze Opioid Pain Patche competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Pain Patche market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Pain Patche and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Pain Patche.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Pain Patche market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Pain Patche industry.

Chapter 3: Detailed analysis of Opioid Pain Patche manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Opioid Pain Patche in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Opioid Pain Patche in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Opioid Pain Patche Industry Trends Table 2. Opioid Pain Patche Industry Drivers Table 3. Opioid Pain Patche Industry Opportunities and Challenges Table 4. Opioid Pain Patche Industry Restraints Table 5. Global Opioid Pain Patche Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Opioid Pain Patche Revenue Share by Company (2021-2026) Table 7. Global Opioid Pain Patche Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Opioid Pain Patche Sales Volume Share by Company (2021-2026) Table 9. Global Opioid Pain Patche Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Opioid Pain Patche Company Ranking, (2024-2026) & (USD Million) Table 11. Global Opioid Pain Patche Key Company Manufacturing Base & Headquarters Table 12. Global Opioid Pain Patche Company, Product Type & Application Table 13. Global Opioid Pain Patche Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioid Pain Patche by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Opioid Patches Table 18. Significant Companies of Non-opioid Patches Table 19. Global Opioid Pain Patche Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Opioid Pain Patche Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Opioid Pain Patche Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Opioid Pain Patche Sales Volume Share by Type (2021-2026) Table 23. Global Opioid Pain Patche Sales Volume Share by Type (2027-2032) Table 24. Global Opioid Pain Patche Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Opioid Pain Patche Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Opioid Pain Patche Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Opioid Pain Patche Sales Value Share by Type (2021-2026) Table 28. Global Opioid Pain Patche Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacies Table 30. Significant Companies of Online pharmacies Table 31. Significant Companies of Hospital Pharmacies Table 32. Global Opioid Pain Patche Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Opioid Pain Patche Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Opioid Pain Patche Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Opioid Pain Patche Sales Volume Share by Application (2021-2026) Table 36. Global Opioid Pain Patche Sales Volume Share by Application (2027-2032) Table 37. Global Opioid Pain Patche Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Opioid Pain Patche Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Opioid Pain Patche Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Opioid Pain Patche Sales Value Share by Application (2021-2026) Table 41. Global Opioid Pain Patche Sales Value Share by Application (2027-2032) Table 42. Global Opioid Pain Patche Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Opioid Pain Patche Sales by Region (2021-2026) & (K Units) Table 44. Global Opioid Pain Patche Sales Market Share by Region (2021-2026) Table 45. Global Opioid Pain Patche Sales by Region (2027-2032) & (K Units) Table 46. Global Opioid Pain Patche Sales Market Share by Region (2027-2032) Table 47. Global Opioid Pain Patche Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Opioid Pain Patche Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Opioid Pain Patche Sales Value Share by Region (2021-2026) Table 50. Global Opioid Pain Patche Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Opioid Pain Patche Sales Value Share by Region (2027-2032) Table 52. Global Opioid Pain Patche Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Opioid Pain Patche Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Opioid Pain Patche Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Opioid Pain Patche Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Opioid Pain Patche Sales by Country (2021-2026) & (K Units) Table 57. Global Opioid Pain Patche Sales Market Share by Country (2021-2026) Table 58. Global Opioid Pain Patche Sales by Country (2027-2032) & (K Units) Table 59. Global Opioid Pain Patche Sales Market Share by Country (2027-2032) Table 60. Global Opioid Pain Patche Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Opioid Pain Patche Sales Value Market Share by Country (2021-2026) Table 62. Global Opioid Pain Patche Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Opioid Pain Patche Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceutical Industries Company Information Table 65. Teva Pharmaceutical Industries Business Overview Table 66. Teva Pharmaceutical Industries Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Opioid Pain Patche Product Portfolio Table 68. Teva Pharmaceutical Industries Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sanofi Opioid Pain Patche Product Portfolio Table 73. Sanofi Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis Opioid Pain Patche Product Portfolio Table 78. Novartis Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Opioid Pain Patche Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. Viatris Company Information Table 85. Viatris Business Overview Table 86. Viatris Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Viatris Opioid Pain Patche Product Portfolio Table 88. Viatris Recent Development Table 89. Teikoku Seiyaku Company Information Table 90. Teikoku Seiyaku Business Overview Table 91. Teikoku Seiyaku Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Teikoku Seiyaku Opioid Pain Patche Product Portfolio Table 93. Teikoku Seiyaku Recent Development Table 94. Nichiban Company Information Table 95. Nichiban Business Overview Table 96. Nichiban Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Nichiban Opioid Pain Patche Product Portfolio Table 98. Nichiban Recent Development Table 99. Mentholatum Company Information Table 100. Mentholatum Business Overview Table 101. Mentholatum Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mentholatum Opioid Pain Patche Product Portfolio Table 103. Mentholatum Recent Development Table 104. Johnson & Johnson Services Company Information Table 105. Johnson & Johnson Services Business Overview Table 106. Johnson & Johnson Services Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Johnson & Johnson Services Opioid Pain Patche Product Portfolio Table 108. Johnson & Johnson Services Recent Development Table 109. Hisamitsu Pharmaceutical Company Information Table 110. Hisamitsu Pharmaceutical Business Overview Table 111. Hisamitsu Pharmaceutical Opioid Pain Patche Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hisamitsu Pharmaceutical Opioid Pain Patche Product Portfolio Table 113. Hisamitsu Pharmaceutical Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Opioid Pain Patche Distributors List Table 117. Opioid Pain Patche Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Opioid Pain Patche Product Image Figure 2. Global Opioid Pain Patche Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Pain Patche Sales Value (2021-2032) & (US$ Million) Figure 4. Global Opioid Pain Patche Sales (2021-2032) & (K Units) Figure 5. Global Opioid Pain Patche Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Opioid Pain Patche Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Opioid Patches Image Figure 10. Non-opioid Patches Image Figure 11. Global Opioid Pain Patche Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Opioid Pain Patche Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Opioid Pain Patche Sales Volume Share by Type (2021-2032) Figure 14. Global Opioid Pain Patche Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Opioid Pain Patche Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Opioid Pain Patche Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacies Image Figure 18. Online pharmacies Image Figure 19. Hospital Pharmacies Image Figure 20. Global Opioid Pain Patche Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Opioid Pain Patche Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Opioid Pain Patche Sales Volume Share by Application (2021-2032) Figure 23. Global Opioid Pain Patche Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Opioid Pain Patche Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Opioid Pain Patche Sales Value Share by Application (2021-2032) Figure 26. Global Opioid Pain Patche Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Opioid Pain Patche Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Opioid Pain Patche Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Opioid Pain Patche Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Opioid Pain Patche Sales Value (2021-2032) & (US$ Million) Figure 31. North America Opioid Pain Patche Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Opioid Pain Patche Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Opioid Pain Patche Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Opioid Pain Patche Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Opioid Pain Patche Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Opioid Pain Patche Sales Value (2021-2032) & (US$ Million) Figure 37. South America Opioid Pain Patche Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Opioid Pain Patche Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Opioid Pain Patche Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Opioid Pain Patche Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Opioid Pain Patche Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Opioid Pain Patche Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Opioid Patches
  • Non-opioid Patches
Applications
  • Retail Pharmacies
  • Online pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Novartis
  • GlaxoSmithKline
  • Viatris
  • Teikoku Seiyaku
  • Nichiban
  • Mentholatum
  • Johnson & Johnson Services
  • Hisamitsu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioid Pain Patche Sales Value (2021-2032)
  4. 1.2.2 Global Opioid Pain Patche Sales Volume (2021-2032)
  5. 1.2.3 Global Opioid Pain Patche Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Opioid Pain Patche Market Dynamics
  1. 2.1 Opioid Pain Patche Industry Trends
  2. 2.2 Opioid Pain Patche Industry Drivers
  3. 2.3 Opioid Pain Patche Industry Opportunities and Challenges
  4. 2.4 Opioid Pain Patche Industry Restraints
3 Opioid Pain Patche Market by Company
  1. 3.1 Global Opioid Pain Patche Company Revenue Ranking in 2025
  2. 3.2 Global Opioid Pain Patche Revenue by Company (2021-2026)
  3. 3.3 Global Opioid Pain Patche Sales Volume by Company (2021-2026)
  4. 3.4 Global Opioid Pain Patche Average Price by Company (2021-2026)
  5. 3.5 Global Opioid Pain Patche Company Ranking (2024-2026)
  6. 3.6 Global Opioid Pain Patche Company Manufacturing Base and Headquarters
  7. 3.7 Global Opioid Pain Patche Company Product Type and Application
  8. 3.8 Global Opioid Pain Patche Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Opioid Pain Patche Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Opioid Pain Patche Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Opioid Pain Patche Market by Type
  1. 4.1 Opioid Pain Patche Type Introduction
  2. 4.1.1 Opioid Patches
  3. 4.1.2 Non-opioid Patches
  4. 4.2 Global Opioid Pain Patche Sales Volume by Type
  5. 4.2.1 Global Opioid Pain Patche Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Opioid Pain Patche Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Opioid Pain Patche Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Opioid Pain Patche Sales Value by Type
  9. 4.3.1 Global Opioid Pain Patche Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Opioid Pain Patche Sales Value by Type (2021-2032)
  11. 4.3.3 Global Opioid Pain Patche Sales Value Share by Type (2021-2032)
5 Opioid Pain Patche Market by Application
  1. 5.1 Opioid Pain Patche Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Opioid Pain Patche Sales Volume by Application
  6. 5.2.1 Global Opioid Pain Patche Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioid Pain Patche Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Opioid Pain Patche Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Opioid Pain Patche Sales Value by Application
  10. 5.3.1 Global Opioid Pain Patche Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Opioid Pain Patche Sales Value by Application (2021-2032)
  12. 5.3.3 Global Opioid Pain Patche Sales Value Share by Application (2021-2032)
6 Opioid Pain Patche Regional Sales and Value Analysis
  1. 6.1 Global Opioid Pain Patche Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioid Pain Patche Sales by Region (2021-2032)
  3. 6.2.1 Global Opioid Pain Patche Sales by Region: 2021-2026
  4. 6.2.2 Global Opioid Pain Patche Sales by Region (2027-2032)
  5. 6.3 Global Opioid Pain Patche Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Opioid Pain Patche Sales Value by Region (2021-2032)
  7. 6.4.1 Global Opioid Pain Patche Sales Value by Region: 2021-2026
  8. 6.4.2 Global Opioid Pain Patche Sales Value by Region (2027-2032)
  9. 6.5 Global Opioid Pain Patche Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Opioid Pain Patche Sales Value (2021-2032)
  12. 6.6.2 North America Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Opioid Pain Patche Sales Value (2021-2032)
  15. 6.7.2 Europe Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Opioid Pain Patche Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Opioid Pain Patche Sales Value (2021-2032)
  21. 6.9.2 South America Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Opioid Pain Patche Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Opioid Pain Patche Sales Value Share by Country, 2025 VS 2032
7 Opioid Pain Patche Country-level Sales and Value Analysis
  1. 7.1 Global Opioid Pain Patche Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Opioid Pain Patche Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Opioid Pain Patche Sales by Country (2021-2032)
  4. 7.3.1 Global Opioid Pain Patche Sales by Country (2021-2026)
  5. 7.3.2 Global Opioid Pain Patche Sales by Country (2027-2032)
  6. 7.4 Global Opioid Pain Patche Sales Value by Country (2021-2032)
  7. 7.4.1 Global Opioid Pain Patche Sales Value by Country (2021-2026)
  8. 7.4.2 Global Opioid Pain Patche Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Opioid Pain Patche Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Opioid Pain Patche Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Opioid Pain Patche Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Opioid Pain Patche Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Opioid Pain Patche Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Opioid Pain Patche Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Opioid Pain Patche Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Viatris
  26. 8.5.1 Viatris Company Information
  27. 8.5.2 Viatris Business Overview
  28. 8.5.3 Viatris Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Viatris Opioid Pain Patche Product Portfolio
  30. 8.5.5 Viatris Recent Developments
  31. 8.6 Teikoku Seiyaku
  32. 8.6.1 Teikoku Seiyaku Company Information
  33. 8.6.2 Teikoku Seiyaku Business Overview
  34. 8.6.3 Teikoku Seiyaku Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Teikoku Seiyaku Opioid Pain Patche Product Portfolio
  36. 8.6.5 Teikoku Seiyaku Recent Developments
  37. 8.7 Nichiban
  38. 8.7.1 Nichiban Company Information
  39. 8.7.2 Nichiban Business Overview
  40. 8.7.3 Nichiban Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nichiban Opioid Pain Patche Product Portfolio
  42. 8.7.5 Nichiban Recent Developments
  43. 8.8 Mentholatum
  44. 8.8.1 Mentholatum Company Information
  45. 8.8.2 Mentholatum Business Overview
  46. 8.8.3 Mentholatum Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mentholatum Opioid Pain Patche Product Portfolio
  48. 8.8.5 Mentholatum Recent Developments
  49. 8.9 Johnson & Johnson Services
  50. 8.9.1 Johnson & Johnson Services Company Information
  51. 8.9.2 Johnson & Johnson Services Business Overview
  52. 8.9.3 Johnson & Johnson Services Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Services Opioid Pain Patche Product Portfolio
  54. 8.9.5 Johnson & Johnson Services Recent Developments
  55. 8.10 Hisamitsu Pharmaceutical
  56. 8.10.1 Hisamitsu Pharmaceutical Company Information
  57. 8.10.2 Hisamitsu Pharmaceutical Business Overview
  58. 8.10.3 Hisamitsu Pharmaceutical Opioid Pain Patche Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hisamitsu Pharmaceutical Opioid Pain Patche Product Portfolio
  60. 8.10.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioid Pain Patche Value Chain Analysis
  2. 9.1.1 Opioid Pain Patche Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioid Pain Patche Sales Mode & Process
  6. 9.2 Opioid Pain Patche Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioid Pain Patche Distributors
  9. 9.2.3 Opioid Pain Patche Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research